FZMD
Fuse Medical, Inc.
Price Chart
Latest Quote
$0.02
| Previous Close | $0.02 |
| Open | $0.02 |
| Day High | $0.02 |
| Day Low | $0.02 |
| Volume | 1 |
Stock Information
| Shares Outstanding | 73.90M |
| Total Debt | $2.22M |
| Cash Equivalents | $253K |
| Revenue | $18.40M |
| Net Income | $3.98M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.48M |
| P/E Ratio | 1.00 |
| EPS (TTM) | $0.02 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.51M |
| Sales | $18.40M |
| Income | $3.98M |
| Book/sh | $-0.00 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.31 |
| Current Ratio | 1.06 |
Returns & Margins
| ROA | 0.35% |
| Gross Margin | 67.25% |
| Operating Margin | 7.38% |
| Profit Margin | 21.61% |
Ownership
| Insider Ownership | 86.89% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.08 |
| P/B | -6.67 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.03 |
| SMA50 | $0.03 |
| SMA200 | $0.05 |
| ATR | 0.0007 |
| Shares Float | 6.12M |
| Volatility | -0.52 |
| Rel Volume | 0.10 |
Performance History
| Week | +0.00% |
| Month | -33.33% |
| Quarter | -50.00% |
| 6 Months | -71.43% |
| YTD | +0.00% |
| Year | -71.43% |
| 3 Years | -66.67% |
| 5 Years | -84.62% |
| 10 Years | -83.33% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $0.02 | 600 |
| 2026-06-18 | $0.02 | 0 |
| 2026-06-17 | $0.02 | 0 |
| 2026-06-16 | $0.02 | 0 |
| 2026-06-15 | $0.02 | 0 |
| 2026-06-12 | $0.02 | 0 |
| 2026-06-11 | $0.02 | 0 |
| 2026-06-10 | $0.02 | 119,300 |
| 2026-06-09 | $0.03 | 0 |
| 2026-06-08 | $0.03 | 0 |
| 2026-06-05 | $0.03 | 0 |
| 2026-06-04 | $0.03 | 0 |
| 2026-06-03 | $0.03 | 0 |
| 2026-06-02 | $0.03 | 0 |
| 2026-06-01 | $0.03 | 0 |
| 2026-05-29 | $0.03 | 0 |
| 2026-05-28 | $0.03 | 0 |
| 2026-05-27 | $0.03 | 0 |
| 2026-05-26 | $0.03 | 0 |
About Fuse Medical, Inc.
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company provides orthopedic implants, including internal and external fixation products; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, substitute bone materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Farmers Branch, Texas.
đ° Latest News
Income Statement (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Revenue | ||
| Reconciled Cost Of Revenue | $7,103,033 | $8,478,561 |
| Cost Of Revenue | $7,103,033 | $8,478,561 |
| Total Revenue | $18,644,784 | $20,414,268 |
| Operating Revenue | $18,644,784 | $20,414,268 |
| Expenses | ||
| Interest Expense | $171,294 | $78,230 |
| Total Expenses | $19,459,856 | $22,609,774 |
| Other Income Expense | $4,108,134 | $703,568 |
| Net Non Operating Interest Income Expense | $-171,294 | $-78,230 |
| Interest Expense Non Operating | $171,294 | $78,230 |
| Operating Expense | $12,356,823 | $14,131,213 |
| Selling And Marketing Expense | $5,682,038 | $7,050,278 |
| General And Administrative Expense | $6,537,382 | $7,013,297 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $3,098,113 | $-1,587,891 |
| Net Interest Income | $-171,294 | $-78,230 |
| Normalized Income | $-977,156 | $-2,101,496 |
| Net Income From Continuing And Discontinued Operation | $3,098,113 | $-1,587,891 |
| Total Operating Income As Reported | $-815,072 | $-2,195,506 |
| Net Income Common Stockholders | $3,098,113 | $-1,587,891 |
| Net Income | $3,098,113 | $-1,587,891 |
| Net Income Including Noncontrolling Interests | $3,098,113 | $-1,587,891 |
| Net Income Continuous Operations | $3,098,113 | $-1,587,891 |
| Pretax Income | $3,121,768 | $-1,570,168 |
| Special Income Charges | $4,108,134 | $703,568 |
| Operating Income | $-815,072 | $-2,195,506 |
| Depreciation Amortization Depletion Income Statement | $137,403 | $67,638 |
| Depreciation And Amortization In Income Statement | $137,403 | $67,638 |
| Gross Profit | $11,541,751 | $11,935,707 |
| Per Share | ||
| Diluted EPS | $0.04 | $-0.02 |
| Basic EPS | $0.04 | $-0.02 |
| Other | ||
| Tax Effect Of Unusual Items | $32,865 | $189,963 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-677,669 | $-2,127,868 |
| Total Unusual Items | $4,108,134 | $703,568 |
| Total Unusual Items Excluding Goodwill | $4,108,134 | $703,568 |
| Reconciled Depreciation | $137,403 | $67,638 |
| EBITDA (Bullshit earnings) | $3,430,465 | $-1,424,300 |
| EBIT | $3,293,062 | $-1,491,938 |
| Diluted Average Shares | $73,895,794 | $70,321,566 |
| Basic Average Shares | $73,895,794 | $70,321,566 |
| Diluted NI Availto Com Stockholders | $3,098,113 | $-1,587,891 |
| Tax Provision | $23,655 | $17,723 |
| Restructuring And Mergern Acquisition | $-4,108,134 | $-342,168 |
| Selling General And Administration | $12,219,420 | $14,063,575 |
| Other Gand A | $6,537,382 | $7,013,297 |
| Other Special Charges | - | $-361,400 |
Balance Sheet (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-3,474,720 | $-6,722,046 |
| Total Assets | $19,762,581 | $18,304,492 |
| Total Non Current Assets | $5,997,339 | $5,479,915 |
| Non Current Accounts Receivable | $2,832,764 | $2,182,437 |
| Goodwill And Other Intangible Assets | $3,163,866 | $3,290,227 |
| Other Intangible Assets | $1,190,980 | $1,317,341 |
| Current Assets | $13,765,242 | $12,824,577 |
| Other Current Assets | $126,022 | $5,921 |
| Inventory | $9,494,506 | $8,736,474 |
| Receivables | $3,996,860 | $3,528,992 |
| Accounts Receivable | $3,996,860 | $3,528,992 |
| Allowance For Doubtful Accounts Receivable | $-290,500 | $-498,261 |
| Gross Accounts Receivable | $4,287,360 | $4,027,253 |
| Cash Cash Equivalents And Short Term Investments | $147,854 | $553,190 |
| Cash And Cash Equivalents | $147,854 | $553,190 |
| Prepaid Assets | - | $5,921 |
| Debt | ||
| Net Debt | $2,199,281 | $2,229,580 |
| Total Debt | $2,347,135 | $2,782,770 |
| Long Term Debt And Capital Lease Obligation | $200,000 | $200,000 |
| Long Term Debt | $200,000 | $200,000 |
| Current Debt And Capital Lease Obligation | $2,147,135 | $2,582,770 |
| Current Debt | $2,147,135 | $2,582,770 |
| Other Current Borrowings | $150,000 | $150,000 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $20,073,435 | $21,736,311 |
| Total Non Current Liabilities Net Minority Interest | $7,685,698 | $11,793,832 |
| Other Non Current Liabilities | $7,485,698 | $11,593,832 |
| Current Liabilities | $12,387,737 | $9,942,479 |
| Payables And Accrued Expenses | $10,240,602 | $7,359,709 |
| Payables | $5,700,236 | $4,461,641 |
| Accounts Payable | $5,700,236 | $4,461,641 |
| Current Notes Payable | - | $0 |
| Equity | ||
| Common Stock Equity | $-310,854 | $-3,431,819 |
| Total Equity Gross Minority Interest | $-310,854 | $-3,431,819 |
| Stockholders Equity | $-310,854 | $-3,431,819 |
| Retained Earnings | $-2,518,086 | $-5,616,199 |
| Other | ||
| Ordinary Shares Number | $73,895,794 | $72,895,793 |
| Share Issued | $73,895,794 | $72,895,793 |
| Tangible Book Value | $-3,474,720 | $-6,722,046 |
| Invested Capital | $2,036,281 | $-649,049 |
| Working Capital | $1,377,505 | $2,882,098 |
| Total Capitalization | $-110,854 | $-3,231,819 |
| Additional Paid In Capital | $1,468,274 | $1,455,422 |
| Capital Stock | $738,958 | $728,958 |
| Common Stock | $738,958 | $728,958 |
| Preferred Stock | $0 | $0 |
| Line Of Credit | $1,997,135 | $2,432,770 |
| Current Accrued Expenses | $4,540,366 | $2,898,068 |
| Goodwill | $1,972,886 | $1,972,886 |
| Net PPE | $709 | $7,251 |
| Accumulated Depreciation | $-19,540 | $-12,998 |
| Gross PPE | $20,249 | $20,249 |
| Machinery Furniture Equipment | $20,249 | $20,249 |
| Finished Goods | $9,494,506 | $8,736,474 |
Cash Flow Statement (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $34,799 | $-1,778,328 |
| Operating Activities | ||
| Operating Cash Flow | $34,799 | $-1,778,328 |
| Cash Flow From Continuing Operating Activities | $34,799 | $-1,778,328 |
| Operating Gains Losses | - | $-361,400 |
| Investing Activities | ||
| Investing Cash Flow | $0 | $0 |
| Cash Flow From Continuing Investing Activities | $0 | $0 |
| Financing Activities | ||
| Financing Cash Flow | $-440,135 | $1,144,060 |
| Cash Flow From Continuing Financing Activities | $-440,135 | $1,144,060 |
| Other | ||
| Repayment Of Debt | $-440,135 | $-1,649,710 |
| Issuance Of Debt | $0 | $2,782,770 |
| Interest Paid Supplemental Data | $160,447 | $42,830 |
| Income Tax Paid Supplemental Data | $18,052 | $19,581 |
| End Cash Position | $147,854 | $553,190 |
| Beginning Cash Position | $553,190 | $1,187,458 |
| Changes In Cash | $-405,336 | $-634,268 |
| Proceeds From Stock Option Exercised | $0 | $11,000 |
| Net Issuance Payments Of Debt | $-440,135 | $1,133,060 |
| Net Short Term Debt Issuance | $-440,135 | $1,283,060 |
| Short Term Debt Payments | $-440,135 | $-1,149,710 |
| Net Long Term Debt Issuance | $0 | $-150,000 |
| Long Term Debt Payments | $0 | $-500,000 |
| Long Term Debt Issuance | $0 | $350,000 |
| Net PPE Purchase And Sale | $0 | $0 |
| Purchase Of PPE | $0 | $0 |
| Change In Working Capital | $-596,173 | $324,071 |
| Change In Payables And Accrued Expense | $2,880,893 | $1,538,383 |
| Change In Accrued Expense | $1,642,298 | $313,334 |
| Change In Payable | $1,238,595 | $1,225,049 |
| Change In Account Payable | $1,238,595 | $1,225,049 |
| Change In Prepaid Assets | $-120,101 | $18,282 |
| Change In Inventory | $-1,471,042 | $-1,168,516 |
| Change In Receivables | $-1,885,923 | $-64,078 |
| Changes In Account Receivables | $-1,885,923 | $-64,078 |
| Other Non Cash Items | $-4,108,134 | $-342,168 |
| Stock Based Compensation | $22,852 | $257,913 |
| Provisionand Write Offof Assets | $1,480,738 | $-136,491 |
| Depreciation Amortization Depletion | $137,403 | $67,638 |
| Depreciation And Amortization | $137,403 | $67,638 |
| Amortization Cash Flow | $130,861 | $57,097 |
| Amortization Of Intangibles | $130,861 | $57,097 |
| Depreciation | $6,542 | $10,540 |
| Net Income From Continuing Operations | $3,098,113 | $-1,587,891 |
| Short Term Debt Issuance | - | $2,432,770 |